Founded in 2002, Plureon strove to develop technologies for regenerative medicine at the Laboratory for Cell Therapy and Tissue Engineering of Childrens Hospital Boston, a teaching affiliate of Harvard Medical School.

Plureon currently develops technology platforms based on pluripotent stem cells extracted from birth tissues. These cells may be used in regenerative medicine and other therapies.

Contact Us for more details.